Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibikase Therapeutics (IKT) Share-based Compensation (2020 - 2026)

Inhibikase Therapeutics (IKT) has 7 years of Share-based Compensation data on record, last reported at $5.6 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 172.24% to $5.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $18.8 million, a 85.87% increase, with the full-year FY2025 number at $15.3 million, up 88.07% from a year prior.
  • Share-based Compensation reached $5.6 million in Q1 2026 per IKT's latest filing, up from $4.5 million in the prior quarter.
  • Over the last five years, Share-based Compensation for IKT hit a ceiling of $7.9 million in Q4 2024 and a floor of $30697.0 in Q2 2024.
  • A 5-year average of $1.8 million and a median of $129781.0 in 2023 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: tumbled 79.15% in 2022, then soared 13610.6% in 2025.
  • Tracing IKT's Share-based Compensation over 5 years: stood at $100363.0 in 2022, then increased by 21.81% to $122249.0 in 2023, then skyrocketed by 6369.14% to $7.9 million in 2024, then crashed by 42.67% to $4.5 million in 2025, then increased by 22.63% to $5.6 million in 2026.
  • Business Quant data shows Share-based Compensation for IKT at $5.6 million in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.